RENN FUND INC (RCG)
US7597201059
Overall RCG gets a fundamental rating of 3 out of 10. We evaluated RCG against 219 industry peers in the Capital Markets industry. RCG scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, RCG is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
In the past year RCG has reported negative net income.
In multiple years RCG reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: RCG reported negative operating cash flow in multiple years.
1.2 Ratios
Looking at the Return On Assets, with a value of -6.34%, RCG is doing worse than 90.74% of the companies in the same industry.
RCG has a worse Return On Equity (-6.39%) than 83.33% of its industry peers.
Looking at the Return On Invested Capital, with a value of 0.06%, RCG is doing worse than 81.48% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -6.34% | ||
| ROE | -6.39% | ||
| ROIC | 0.06% |
ROA(3y)-1.31%
ROA(5y)0.86%
ROE(3y)-1.33%
ROE(5y)1.1%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
RCG has a Operating Margin of 3.50%. This is amonst the worse of the industry: RCG underperforms 80.09% of its industry peers.
Looking at the Gross Margin, with a value of 73.94%, RCG is in the better half of the industry, outperforming 77.31% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.5% | ||
| PM (TTM) | N/A | ||
| GM | 73.94% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
Compared to 1 year ago, RCG has about the same amount of shares outstanding.
Compared to 5 years ago, RCG has more shares outstanding
RCG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
RCG has an Altman-Z score of 85.10. This indicates that RCG is financially healthy and has little risk of bankruptcy at the moment.
RCG has a Altman-Z score of 85.10. This is amongst the best in the industry. RCG outperforms 100.00% of its industry peers.
There is no outstanding debt for RCG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 85.1 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
RCG has a Current Ratio of 0.77. This is a bad value and indicates that RCG is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of RCG (0.77) is worse than 62.50% of its industry peers.
RCG has a Quick Ratio of 0.77. This is a bad value and indicates that RCG is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of RCG (0.77) is worse than 62.04% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.77 | ||
| Quick Ratio | 0.77 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 79.10% over the past year.
RCG shows a strong growth in Revenue. In the last year, the Revenue has grown by 27.92%.
Measured over the past years, RCG shows a very strong growth in Revenue. The Revenue has been growing by 35.03% on average per year.
EPS 1Y (TTM)79.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-29394.74%
Revenue 1Y (TTM)27.92%
Revenue growth 3Y57.96%
Revenue growth 5Y35.03%
Sales Q2Q%26.26%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for RCG. In the last year negative earnings were reported.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for RCG!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
RENN FUND INC
NYSEARCA:RCG (12/27/2024, 8:04:01 PM)
2.41
-0.05 (-2.03%)
Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)
Earnings (Next)
Inst Owners15.83%
Inst Owner Change7.39%
Ins Owners6.51%
Ins Owner Change42.23%
Market Cap16.92M
Analysts0
Price TargetN/A
Short Float %0.13%
Short Ratio0.38
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DP0%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 59.19 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 1.22 | ||
| P/tB | 1.22 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.13
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.04
BVpS1.97
TBVpS1.97
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -6.34% | ||
| ROE | -6.39% | ||
| ROCE | 0.07% | ||
| ROIC | 0.06% | ||
| ROICexc | 0.06% | ||
| ROICexgc | 0.06% | ||
| OM | 3.5% | ||
| PM (TTM) | N/A | ||
| GM | 73.94% | ||
| FCFM | N/A |
ROA(3y)-1.31%
ROA(5y)0.86%
ROE(3y)-1.33%
ROE(5y)1.1%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.02
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.77 | ||
| Quick Ratio | 0.77 | ||
| Altman-Z | 85.1 |
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)79.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-29394.74%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)27.92%
Revenue growth 3Y57.96%
Revenue growth 5Y35.03%
Sales Q2Q%26.26%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y154.18%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A